Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00480064
Status:
COMPLETED
Last Update Posted:
2007-05-30
First Post:
2007-05-29
Brief Title:
Lomustine and Intermediate Dose Cytarabine in Older Patients With AML
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Organization Data
Organization:
French Innovative Leukemia Organisation
Class:
OTHER
Study ID:
BGMT95-V
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French Innovative Leukemia Organisation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None